Daniel Rader of the Perelman School of Medicine comments on the price and effectiveness of new cholesterol-lowering drugs called PCSK9 inhibitors.
http://www.usatoday.com/story/news/2015/06/08/pcsk9-inhibitors-fda-review/28696877/ USA TodayDaniel Rader of the Perelman School of Medicine comments on the price and effectiveness of new cholesterol-lowering drugs called PCSK9 inhibitors.
http://www.usatoday.com/story/news/2015/06/08/pcsk9-inhibitors-fda-review/28696877/ USA Today